Marinus Pharmaceuticals Inc. (MRNS) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Marinus Pharmaceuticals I...

    NASDAQ: MRNS · Real-Time Price · USD
    0.55
    0.00 (0.00%)
    At close: Feb 10, 2025, 3:59 PM

    Marinus Pharmaceuticals Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -141.41M -19.82M -98.78M
    Depreciation & Amortization
    		 551K 418K 355K
    Stock-Based Compensation
    		 15.56M 14.89M 13.87M
    Other Working Capital
    		 -2.55M -4.27M 20.86M
    Other Non-Cash Items
    		 5.12M -102.29M 1.06M
    Deferred Income Tax
    		 n/a n/a -687K
    Change in Working Capital
    		 2.17M -6.09M 28.7M
    Operating Cash Flow
    		 -118M -112.89M -55.48M
    Capital Expenditures
    		 -119K -1.77M -2.89M
    Cash Acquisitions
    		 n/a 171K n/a
    Purchase of Investments
    		 -51.99M -171K n/a
    Sales Maturities Of Investments
    		 23.5M 107.38M 1.47M
    Other Investing Acitivies
    		 9K 171K 1.47M
    Investing Cash Flow
    		 -28.61M 105.77M -1.42M
    Debt Repayment
    		 n/a 58.51M 40.26M
    Common Stock Repurchased
    		 n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a
    Other Financial Acitivies
    		 804K 1.75M 1.05M
    Financial Cash Flow
    		 26.63M 124.74M 41.31M
    Net Cash Flow
    		 -119.98M 117.62M -15.58M
    Free Cash Flow
    		 -118.12M -114.66M -58.37M

    Add to Watchlist